Durch Moxifloxacin-Augentropfen induziertes Hornhautödem
Abstract
Purpose. This case report describes a case of acute unilateral central corneal edema in a patient undergoing treatment with topical moxifloxacin 0.5% ophthalmic solution for bacterial keratitis secondary to contact lens wear. Material and Methods. During a problem-focused exam of an acute red eye, clinical examination with a Haag Streit slit lamp and sodium fluorescein dye revealed a 3 × 3 mm corneal ulcer and associated anterior chamber reaction in the left eye. The patient was started on moxifloxacin 0.5% ophthalmic solution q1h OS and cyclopentolate 1% TID OS. On day 3, there was 95% re-epithelialization of the corneal ulcer and significant improvement in symptoms. Unexpectedly, the patient’s best corrected visual acuity in the left eye deteriorated from baseline due to new onset central corneal edema. Moxifloxacin was discontinued and the patient was started on ciprofloxacin 0.3% ophthalmic solution QID OS and instructed to return to office in 2 days for follow-up. Results. On day 5, there was complete epithelialization of the corneal ulcer with a resolving subepithelial infiltrate. The central stromal edema and anterior chamber reaction were completely resolved. Conclusion. Acute corneal stromal edema is a possible side-effect of topical moxifloxacin use. Eye care providers must be aware of this potential side-effect when making therapeutic decisions for bacterial keratitis treatment.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.